Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 2014

View Archived Issues

New consortium to develop PDE inhibitors for neglected parasitic diseases

CalciMedica patent divulges novel Ca2+ channel modulators

Daiichi Sankyo and UCSF collaborate on drugs for neurodegenerative diseases

New murine models created to investigate type 1 hereditary hemorrhagic telangiectasia

US Oncology Research teams up with Corcept Therapeutics for mifepristone trial

MK-5172/MK-8742 combination effective in phase II C-WORTHY trial

Pfizer reports discovery of novel CRTH2 antagonists

Glenmark Pharmaceuticals' GRC-27864 enters human trials

Dyax receives FDA approval to expand the use of Kalbitor

Amgen reports topline results from phase III study of talimogene laherparepvec

Roche patent reports new FABP inhibitors

New BTK inhibitors designed by KBP BioSciences

ViiV Healthcare and MPP to improve access to dolutegravir

Scientists at Nanjing Sanhome Pharmaceutical disclose novel BCR-ABL1 inhibitors

Co-formulation of migalastat HCl and alpha-Gal A enhances stability and potency of the enzyme

Santen's SAKURA study meets primary endpoint in posterior segment uveitis

FDA approves Evzio for the emergency treatment of opioid overdose

MT-3724 shows significant antitumor activity in vitro and in vivo

Halozyme suspends enrollment and dosing in phase II trial of PEGPH-20 for pancreatic cancer

New START2 trial investigates tecemotide in stage III NSCLC

Genzyme to resubmit Lemtrada sBLA in U.S.

FDA extends PDUFA date for Afrezza review

Cellular Biomedicine initiates phase IIb trial of cell therapy for knee osteoarthritis

FDA awards breakthrough therapy designation to Bexsero

Preclinical efficacy of novel PDE10A inhibitors suggests potential for schizophrenia therapy

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...